These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
359 related articles for article (PubMed ID: 29360561)
1. Epigenetic and epitranscriptomic changes in colorectal cancer: Diagnostic, prognostic, and treatment implications. Porcellini E; Laprovitera N; Riefolo M; Ravaioli M; Garajova I; Ferracin M Cancer Lett; 2018 Apr; 419():84-95. PubMed ID: 29360561 [TBL] [Abstract][Full Text] [Related]
2. Epigenetic biomarkers in colorectal cancer: premises and prospects. Zamani M; Hosseini SV; Mokarram P Biomarkers; 2018 Mar; 23(2):105-114. PubMed ID: 27788596 [TBL] [Abstract][Full Text] [Related]
3. Epigenetic alterations in the gastrointestinal tract: Current and emerging use for biomarkers of cancer. Grady WM Adv Cancer Res; 2021; 151():425-468. PubMed ID: 34148620 [TBL] [Abstract][Full Text] [Related]
4. Epigenetic Biomarkers in Colorectal Cancer. Verma M; Kumar V Mol Diagn Ther; 2017 Apr; 21(2):153-165. PubMed ID: 27878475 [TBL] [Abstract][Full Text] [Related]
5. Decoding colorectal cancer epigenomics. El Bairi K; Tariq K; Himri I; Jaafari A; Smaili W; Kandhro AH; Gouri A; Ghazi B Cancer Genet; 2018 Jan; 220():49-76. PubMed ID: 29310839 [TBL] [Abstract][Full Text] [Related]
10. DNA methylation and microRNA biomarkers for noninvasive detection of gastric and colorectal cancer. Toiyama Y; Okugawa Y; Goel A Biochem Biophys Res Commun; 2014 Dec; 455(1-2):43-57. PubMed ID: 25128828 [TBL] [Abstract][Full Text] [Related]
11. Epigenetic biomarkers of colorectal cancer: Focus on DNA methylation. Coppedè F Cancer Lett; 2014 Jan; 342(2):238-47. PubMed ID: 22202641 [TBL] [Abstract][Full Text] [Related]
12. MicroRNA Methylation in Colorectal Cancer. Kaur S; Lotsari-Salomaa JE; Seppänen-Kaijansinkko R; Peltomäki P Adv Exp Med Biol; 2016; 937():109-22. PubMed ID: 27573897 [TBL] [Abstract][Full Text] [Related]
13. The role of epigenetic therapies in colorectal cancer. Baretti M; Azad NS Curr Probl Cancer; 2018 Nov; 42(6):530-547. PubMed ID: 29625794 [TBL] [Abstract][Full Text] [Related]
14. Post-translational histone modifications in circulating nucleosomes as new biomarkers in colorectal cancer. Gezer U; Holdenrieder S In Vivo; 2014; 28(3):287-92. PubMed ID: 24815828 [TBL] [Abstract][Full Text] [Related]
15. Diagnostic and prognostic epigenetic biomarkers in cancer. Costa-Pinheiro P; Montezuma D; Henrique R; Jerónimo C Epigenomics; 2015; 7(6):1003-15. PubMed ID: 26479312 [TBL] [Abstract][Full Text] [Related]
16. Molecular biomarkers for an early diagnosis, effective treatment and prognosis of colorectal cancer: Current updates. Mahasneh A; Al-Shaheri F; Jamal E Exp Mol Pathol; 2017 Jun; 102(3):475-483. PubMed ID: 28506769 [TBL] [Abstract][Full Text] [Related]
17. Epigenetic and Epitranscriptomic Control in Prostate Cancer. López J; Añazco-Guenkova AM; Monteagudo-García Ó; Blanco S Genes (Basel); 2022 Feb; 13(2):. PubMed ID: 35205419 [TBL] [Abstract][Full Text] [Related]
18. m6A RNA methylation and beyond - The epigenetic machinery and potential treatment options. Garbo S; Zwergel C; Battistelli C Drug Discov Today; 2021 Nov; 26(11):2559-2574. PubMed ID: 34126238 [TBL] [Abstract][Full Text] [Related]
19. Cancer epigenetics: an introduction. Kanwal R; Gupta K; Gupta S Methods Mol Biol; 2015; 1238():3-25. PubMed ID: 25421652 [TBL] [Abstract][Full Text] [Related]
20. Methylation of Zheng R; Gao D; He T; Zhang M; Zhang X; Linghu E; Wei L; Guo M Clin Epigenetics; 2017; 9():50. PubMed ID: 28491151 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]